Future US Nucleic Acid Testing Market Outlook

Venture Planning Group
February 14, 2012
880 Pages - SKU: VPG6827395
Countries covered: United States

Highlights
  • Comprehensive 880-page market segmentation analysis of the US NAT market.
  • Major issues pertaining to the US NAT laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
  • An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods.
  • Ten-year test volume and reagent sales forecasts for the following categories:
- Infectious Diseases
- Cancer
- Forensic Testing
- Genetic Diseases
- Paternity Testing/HLA Typing
  • Review of testing methodologies and instrumentation technologies.
  • Feature comparison of automated and semiautomated analyzers.
  • Sales and market shares of leading suppliers.
  • Over 60 specific opportunities for NAT instruments, test systems, IT and auxiliary products.
  • Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
  • Alternative market penetration strategies.
  • Potential market entry barriers and risks.
  • Business planning issues and concerns.
Contains 880 pages and 37 tables

Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.



More Antisense & RNAi Technology reports by Venture Planning Group

Analysis of Nucleic Acid Testing Technologies And Strategic Profiles of Leading Suppliers by Venture Planning Group
This 180-page report provides detailed analyses of current and emerging nucleic acid testing technologies, and their potential market applications, including DNA sequencing, RNA probes, detection ...
Analysis of Nucleic Acid Testing Instrumentation And Strategic Profiles of Leading Suppliers by Venture Planning Group
This 103-page report is designed to help suppliers identify and evaluate emerging opportunities for further automating NAT methods in order to facilitate their penetration into ...
Analysis of Emerging Nucleic Acid Testing Assays And Strategic Profiles of Leading Suppliers by Venture Planning Group
This 549-page report presents an overview of the clinical significance and market needs for major current and emerging NAT assays, as well as extensive listings ...
Analysis of the World Nucleic Acid Testing Market Sales Forecasts by Country and Strategic Profiles of Leading Suppliers by Venture Planning Group
This report provides a worldwide overview of the nucleic acid testing market, including estimates of facilities performing DNA sequencing and molecular diagnostic testing, as well ...
See all reports like this >>

More United States Antisense & RNAi Technology reports

Future Horizons in the US Nucleic Acid Testing Market: Supplier Shares and Sales Forecasts for 35 Tests and Applications by Market Segment by Venture Planning Group
Highlights Comprehensive 880-page market segmentation analysis of the US NAT market. Major issues pertaining to the US NAT laboratory practice, as well as ...
2012 US Nucleic Acid Testing Market Outlook: Growth Opportunities and Strategies by Venture Planning Group
Highlights Comprehensive 880-page market segmentation analysis of the US NAT market. Major issues pertaining to the ...
Opportunities in Stem Cell Technology by Kalorama Information
In the nascent, but rapidly growing field of stem cell therapies, products are a long way from being commercialized. However, the market potential for stem ...
The U.S. Market and Developments Associated with Psoriasis by Kalorama Information
Psoriasis has long been a dermatological problem that affects millions of people in the US. Current therapeutic approaches such as lubricants, keratolytic agents and topical ...
See all reports like this >>

More United States reports

The 2013-2018 Outlook for Collagen and (hyaluronic Acid) HA-Based Biomaterials in the United States by Icon Group International, Inc.
The 2013-2018 Outlook for Collagen and (hyaluronic Acid) HA-Based Biomaterials in the United StatesThis econometric study covers the latent demand outlook for collagen and (hyaluronic ...
The 2013-2018 Outlook for Relish in the United States by Icon Group International, Inc.
This econometric study covers the latent demand outlook for relish across the states and cities of the United States. Latent demand (in millions of U.S. ...
D&B Country RiskLine Report: The United States of America by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country Report: The United States of America by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
See all reports like this >>

 

SELECT A LICENSE

    PDF E-mail From Publisher  USD 8,400  
    Global Site License Fulfilled by Publisher  USD 18,500  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!